الفهرس 
HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDRENOnly 14 pages are availabe for public view
 |  | from | 267 |  |  |
| | | from | 267 | | |
Abstract
growth hormone deficiency (GHD) related to primary disease.No variable was associated with short stature in the multivariate regression analysis.
Conclusion: We confirmed a high prevalence of MetS components, specifically dyslipidemia (68.2%) and insulin resistance (36.4%) among HSCT survivors despite non exposure to irradiation. 18.2% were to found have short stature and 9.1% were found to have growth hormone deficiency with the most important contributor to growth failure being the primary disease. Screening and management of MetS and Growth retardation should be integrated within models of routine long-term follow-up care after HSCT.